Founding Executive Editor at Wired magazine Kevin Kelly is here with “Excellent Advice for Living … Wisdom I Wish I’d Known Earlier.” Then two different efforts from the front lines of fighting cancer. Dr. Paul Lammers from Triumvira Immunologics tells us about their approach, both as a complement to such existing treatments as Keytruda, and as a standalone cancer drug in its own. Then Dr. Philip Kantoff from Convergent Therapeutics tells about their efforts in the most advanced, intractable prostate cancer.
